Kidney Function Comparable After PN vs AS for Oncocytomas
Surgery should be reserved for select patients with oncocytomas, according to investigators.
Surgery should be reserved for select patients with oncocytomas, according to investigators.
The decision to undergo partial instead of radical nephrectomy should be individualized, according to investigators.
Percutaneous cryoablation for cT1b renal tumors is associated with a higher rate of local disease recurrence compared with partial nephrectomy, new data suggest.
Incidence and mortality rates for major genitourinary cancers differ according to sex, race/ethnicity, and geographic region.
Renal cell carcinoma patients with NF2 driver mutations often present with metastatic disease and have worse survival outcomes, research suggests.
Tivozanib improves long-term progression-free survival, when compared with sorafenib, in patients with relapsed or refractory metastatic renal cell carcinoma, an analysis suggests.
Immunotherapy-based combinations have overtaken TKI monotherapy as the most-used first-line treatment for mRCC in US oncology clinics, a study suggests.
Patients receiving first-line pembrolizumab-axitinib for metastatic renal cell carcinoma have lower health care resource utilization than patients receiving ipilimumab-nivolumab.
Following the 2013 AUA guidelines on surveillance after partial nephrectomy can improve metastasis-free survival, a study suggests.
CBM588, a live bacterial product, improves the efficacy of first-line treatment with nivolumab and ipilimumab in patients with metastatic renal cell carcinoma, a study suggests.